Third article in Paolo's Biotech Notes series. PDF attached and uploaded. Additionally, Paolo has provided a relevant timely article. ContraFect Corp (CFRX) has a promising pipeline with a potential ...
Bank of America Securities writes that SMid-cap biotech, companies with small to mid-sized market capitalizations, had a rocky start to the year. Many companies in the coverage are down 20-40% year-to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results